Literature DB >> 31079292

Reducing complexity in acid-base diagnosis - how far should we go?

Thomas J Morgan1.   

Abstract

PURPOSE: To place in context the potential value of isolated plasma strong ion difference (SID) calculations and strong ion gap (SIG) calculations versus suggested cut-down versions such as SIDa adj and the BICgap respectively.
METHODS: Stewart's physical chemical approach is seen as a mathematical model of isolated plasma not displacing traditional Copenhagen and Boston approaches. Scanning tools for unmeasured ions based on the Principle of Electrical Neutrality such as the SIG and suggested cut-down versions such as the albumin adjusted anion gap and the BICgap are evaluated for accuracy and clinical usefulness.
RESULTS: Plasma SID and abbreviations such as SIDa adj are not independent variables in vivo since they vary with PCO due to Gibbs Donnan ion traffic. They can also exhibit positive and negative bias, and SID values must be partnered with non-volatile weak acid concentrations when evaluating metabolic acid-base status. The BICgap calculation is a cut down version of the SIG fixed for pH 7.4. It includes phosphate but is otherwise similar in form to the albumin corrected anion gap, with similar sensitivity and specificity characteristics.
CONCLUSIONS: Clinicians are unlikely to find SID calculations or cut-down versions such as the SIDa adj clinically useful. The albumin corrected anion gap is in current use and easily determined by mental arithmetic from point of care anion gap printouts plus recent plasma albumin measurements. Any slight advantage of the BICgap would be offset by the complexity of its calculation.

Entities:  

Keywords:  Strong ion difference; Strong ion gap

Mesh:

Substances:

Year:  2019        PMID: 31079292     DOI: 10.1007/s10877-019-00319-7

Source DB:  PubMed          Journal:  J Clin Monit Comput        ISSN: 1387-1307            Impact factor:   2.502


  25 in total

Review 1.  Determinants of plasma acid-base balance.

Authors:  John A Kellum
Journal:  Crit Care Clin       Date:  2005-04       Impact factor: 3.598

2.  The Stewart approach--one clinician's perspective.

Authors:  T John Morgan
Journal:  Clin Biochem Rev       Date:  2009-05

3.  Anion gap and hypoalbuminemia.

Authors:  J Figge; A Jabor; A Kazda; V Fencl
Journal:  Crit Care Med       Date:  1998-11       Impact factor: 7.598

4.  A quantitative physicochemical approach to acid-base physiology.

Authors:  N L Jones
Journal:  Clin Biochem       Date:  1990-06       Impact factor: 3.281

5.  Ethylene glycol poisoning: pharmacokinetics during therapy with ethanol and hemodialysis.

Authors:  C D Peterson; A J Collins; J M Himes; M L Bullock; W F Keane
Journal:  N Engl J Med       Date:  1981-01-01       Impact factor: 91.245

6.  A comprehensive, computer-model-based approach for diagnosis and treatment of complex acid-base disorders in critically-ill patients.

Authors:  Matthew B Wolf; Edward C Deland
Journal:  J Clin Monit Comput       Date:  2011-11-12       Impact factor: 2.502

7.  Comparison of a new simplified acid-base tool to the original Stewart-Figge approach: a study on cardiac surgical patients.

Authors:  Michalis Agrafiotis; Dimitrios Mpliamplias; Maria Papathanassiou; Fotini Ampatzidou; Georgios Drossos
Journal:  J Anesth       Date:  2018-05-03       Impact factor: 2.078

8.  Equivalent metabolic acidosis with four colloids and saline on ex vivo haemodilution.

Authors:  T J Morgan; M Vellaichamy; D M Cowley; S L Weier; B Venkatesh; M A Jones
Journal:  Anaesth Intensive Care       Date:  2009-05       Impact factor: 1.669

9.  Base excess or buffer base (strong ion difference) as measure of a non-respiratory acid-base disturbance.

Authors:  O Siggaard-Andersen; N Fogh-Andersen
Journal:  Acta Anaesthesiol Scand Suppl       Date:  1995

10.  Incidence and outcome of adults with diabetic ketoacidosis admitted to ICUs in Australia and New Zealand.

Authors:  Balasubramanian Venkatesh; David Pilcher; John Prins; Rinaldo Bellomo; Thomas John Morgan; Michael Bailey
Journal:  Crit Care       Date:  2015-12-29       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.